搜索临床试验以:discontinuation treatment TKI
总计63807个结果
-
Poitiers University Hospital招聘中
-
Medical College of WisconsinH. Jean Khoury Cure CML Consortium招聘中
-
European LeukemiaNetLudwig-Maximilians - University of Munich; Heidelberg University主动,不招人
-
National Research Center for Hematology, Russia主动,不招人
-
Fujian Cancer Hospital尚未招聘
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySuzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Massachusetts General HospitalFoundation Medicine招聘中
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.尚未招聘
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...招聘中
-
Degan LuWu Jieping Medical Foundation尚未招聘肺癌 | 安罗替尼 | TKI耐药 | EGFR敏感突变 | 平珠单抗
-
Fondazione Policlinico Universitario Agostino Gemelli...Fundacion Clinic per a la Recerca Biomédica; Newcastle University; University of Glasgow招聘中
-
Bridge Biotherapeutics, Inc.招聘中
-
4th Military Clinical Hospital with Polyclinic,...招聘中
-
The Second Affiliated Hospital of Shandong First...招聘中
-
Xiangya Hospital of Central South UniversitySuzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Second Xiangya Hospital of Central South UniversityThe First Affiliated Hospital of Nanchang University; Xiangya Hospital of Central South University 和其他合作者招聘中肺癌,非小细胞 | 循环肿瘤DNA | 表皮生长因子受体基因突变 | EGFR-TKI 耐药突变 | 初级阻力中国
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Fujian Cancer Hospital尚未招聘经组织病理学或细胞学证实的非小细胞肺癌 | TNM(第 8 期)是 IV | 有 EGFR 突变 | 既往含铂双药化疗和第三代EGFR-TKI治疗后发生脑膜进展 | 男女不限 | 18岁或以上的年龄 | ECOG PS 0 至 2 分
-
Insel Gruppe AG, University Hospital BernUniversity of Bern招聘中
-
Insel Gruppe AG, University Hospital BernUniversity of Bern招聘中
-
University of British ColumbiaCentre for Addiction and Mental Health; Canadian Institutes of Health Research (CIHR); McMaster... 和其他合作者招聘中
-
Tongji Hospital招聘中肝细胞癌 | 免疫疗法的效果 | 程序性细胞死亡 1中国
-
Institute of Mother and Child, Warsaw, PolandMaria Sklodowska-Curie National Research Institute of Oncology招聘中
-
The First Affiliated Hospital of Zhengzhou UniversityBeiGene; Jiangsu Hengrui Pharmaceutical Co., Ltd.; RemeGen Co., Ltd.尚未招聘HER2 阳性或突变的晚期结直肠癌
-
Shenzhen Second People's Hospital招聘中
-
Fudan University招聘中癌肉瘤 | 肉瘤样癌 | PD-1免疫疗法 | VEGFR-TKI中国
-
University Hospital, Bordeaux招聘中在使用 PD1/PDL1 ICIs + VEGFR-酪氨酸激酶抑制剂治疗 12 个月时有客观反应的 mRCC 患者中只有一个不良预后因素的 IMDC 良好或中等风险的治疗暂停与治疗继续 (SPICI)转移性肾细胞癌 | 每个 IMDC 评分的良好或只有一个不良预后因素中等风险法国
-
Universitätsklinikum Hamburg-EppendorfUniversity Hospital, Essen; Philipps University Marburg Medical Center; Helmut Schmidt University招聘中
-
University Hospital Inselspital, BerneUniversity of Bern招聘中
-
Affiliated Hospital of Nantong University招聘中